Navigation Links
Unilife Announces Results of 2013 Annual General Meeting
Date:11/22/2013

YORK, Pa., Nov. 22, 2013 /PRNewswire/ -- Unilife Corporation ("Unilife") (NASDAQ: UNIS, ASX: UNS) today announced that all of the proposed items for its 2013 Annual General Meeting of stockholders were approved by the Company's shareholders. 

The Company also announced changes to the Board of Directors and management team, including the appointment of Alan Shortall to Chairman of the Board of Directors, following Slavko James Joseph (Jim) Bosnjak's decision to step down from the position for both personal and professional reasons.  Mr. Bosnjak will remain on the Board as Deputy Chairman and Lead Independent Director. Mr. Shortall will retain his role as CEO of Unilife. Dr. Ramin Mojdeh was appointed President of the Company, and will retain his position as Chief Operating Officer.

The Company has posted a complete audio archive of the meeting, along with the slide show presentation from Unilife CEO Mr. Alan Shortall focusing on the Company's commercial pipeline on its website at http://ir.unilife.com/events.cfm

"I have tirelessly worked with Jim to accomplish great things for Unilife. And I speak for everyone at the Company, including the other members of the Board, when saying that we are lucky to have convinced Jim to remain with us as Deputy Chairman," said Mr. Shortall.  "I would also like to thank the members of the board of directors for their confidence and appointing me Chairman.  I believe that being Chairman and CEO will have some clear, near-term benefits in the negotiation of contracts."

"I would like to congratulate Ramin on his appointment to President. He has been a driving force behind our rapid ascent to the top of the drug delivery systems business and his work ethic, experience and leadership have bee
'/>"/>

SOURCE Unilife Corporation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Unilife Signs Long-Term Supply Agreement with Hikma to Enhance Delivery of Generic Injectables
2. Unilife Corporation Announces Financial Results For Fiscal Year 2014 First Quarter
3. Unilife Announces Supply Agreement with MedImmune for Wearable Injectable Drug Delivery Devices
4. Unilife Issues Letter to Stockholders Regarding Securities Class Action Lawsuit
5. Unilife Corporation To Announce Financial Results For Fiscal 2014 First Quarter Monday, November 11, 2013
6. Unilife Corporation Announces Financial Results For Fiscal Year 2013 Fourth Quarter
7. Unilife to Present at the Morgan Stanley Global Healthcare Conference in New York City on September 11th
8. Unilife Corporation To Announce Financial Results For Fiscal Year 2013 Fourth Quarter And Year End On Tuesday, September 10, 2013
9. Early Morning Insight: Baxter, CareFusion, Unilife, and Mindray Medical
10. Unilife Launches New Corporate Website
11. Unilife to Present at the Jefferies 2013 Global Healthcare Conference in New York City on June 4th
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2014)... 19, 2014 Intarcia Therapeutics, Inc. ... for its lead candidate ITCA 650 (continuous subcutaneous delivery ... baseline HbA1c levels at the 50 th Annual ... Diabetes (EASD). Data from the open-label, phase 3 FREEDOM-HBL ... sugar in patients with poorly controlled type 2 diabetes. ...
(Date:9/19/2014)... September 19, 2014 Reductions in ... many years in people with diabetes type 2 ... term benefits for the kidneys." Australian researchers ... type 2 diabetes leads to persistent reductions in kidney ... The global study has found that, five and ...
(Date:9/18/2014)... 18, 2014  Low T Center endorses the ... Hyattsville, Maryland earlier this ... proper patient population for testosterone therapy (TRT), as ... with TRT. Examining recent claims from studies that TRT ... epidemiological studies do not provide convincing evidence that ...
Breaking Medicine Technology:Intarcia Announces Presentation of Phase 3 Data at EASD Showing ITCA 650 Markedly Reduces Blood Sugar In Patients With Poorly Controlled Type 2 Diabetes 2Intarcia Announces Presentation of Phase 3 Data at EASD Showing ITCA 650 Markedly Reduces Blood Sugar In Patients With Poorly Controlled Type 2 Diabetes 3Intarcia Announces Presentation of Phase 3 Data at EASD Showing ITCA 650 Markedly Reduces Blood Sugar In Patients With Poorly Controlled Type 2 Diabetes 4ADVANCE-ON Post-trial Observational Study: Blood Pressure Arm and Glucose Arm Results 2ADVANCE-ON Post-trial Observational Study: Blood Pressure Arm and Glucose Arm Results 3Low T Center Endorses The Joint FDA Committee Meeting on Testosterone 2
... DEERFIELD, IL, June 04, 2007,/PRNewswire-FirstCall/ - Cardiome ... US, Inc. ("Astellas") today,announced results from their ... 2. The trial evaluated the efficacy and ... (iv)") for the treatment of patients who ...
... -- ZymoGenetics,Inc. today announced that interim findings were ... in B-cell chronic,lymphocytic leukemia (B-CLL) at the American ... study included intravenous,administration of higher doses than had ... atacicept was well-tolerated and biologically,active at all dose ...
Cached Medicine Technology:Cardiome And Astellas Announce Positive Results From ACT 2 Trial 2Cardiome And Astellas Announce Positive Results From ACT 2 Trial 3Cardiome And Astellas Announce Positive Results From ACT 2 Trial 4Cardiome And Astellas Announce Positive Results From ACT 2 Trial 5Cardiome And Astellas Announce Positive Results From ACT 2 Trial 6ZymoGenetics Reports Results From Atacicept Phase 1b Clinical Trial,in B-Cell Chronic Lymphocytic Leukemia 2ZymoGenetics Reports Results From Atacicept Phase 1b Clinical Trial,in B-Cell Chronic Lymphocytic Leukemia 3
(Date:9/20/2014)... (PRWEB) September 20, 2014 The Arizona ... College (MCC) is celebrating National Manufacturing Day by opening ... enhanced machining, processing and additive manufacturing labs will be ... 3, 2014 at MCC’s Southern and Dobson campus (1833 ... in southeast Lot D. , The AzAMI at MCC ...
(Date:9/20/2014)... Nevada (PRWEB) September 20, 2014 ... extremely successful showing at the PAIN Week conference ... Cosmopolitan Hotel and Casino in Las Vegas from ... MarijuanaDoctors.com primarily attended PAIN Week in the hopes ... as a viable and legitimate tool to treat ...
(Date:9/19/2014)... 20, 2014 Consistent premium price ... the Vision Insurance industry in recent years; however, ... of industry margins. From 2009 to 2014, industry ... provide coverage for routine eye exams and other ... contact lens and refractive surgery. According to IBISWorld ...
(Date:9/19/2014)... September 19, 2014 Unbound , an ... families in regions of the Philippines being affected by both ... than 1,060 families evacuated to the nearest public schools while ... heavy rain and gusty winds to portions of the northern ... flooding. Some homes filled with more than 10 feet of ...
(Date:9/19/2014)... York, NY (PRWEB) September 19, 2014 ... PR News at the Platinum PR and Top Places ... Hyatt in New York City. Camino received honorable mentions ... Shoestring Campaign” — for its work elevating Latina voices ... this incredible organization and be a part of its ...
Breaking Medicine News(10 mins):Health News:National Manufacturing Day Open House at Mesa Community College Oct. 3 2Health News:MarijuanaDoctors.com Experiences Unprecedented Support and Growth at Pain Week 2014 2Health News:Vision Insurance in the US Industry Market Research Report from IBISWorld Has Been Updated 2Health News:Vision Insurance in the US Industry Market Research Report from IBISWorld Has Been Updated 3Health News:Vision Insurance in the US Industry Market Research Report from IBISWorld Has Been Updated 4Health News:Double Threat in Philippines Displaces Thousands of Unbound Families 2Health News:Camino Public Relations Honored for Raising Latina Voices in National Health Care, Immigration Debates 2
... (Nasdaq: GTIV ), a leading provider of comprehensive home,health ... conferences hosted by Oppenheimer & Co., Credit Suisse and,Stephens Inc., ... -- 1:20 p.m. to 1:55 p.m. ET, Monday, November ... & Co. 19th Annual Healthcare Conference in New York. ...
... SGP ) said today that it strongly ... Missouri related to reimbursement by,Missouri,s Medicaid program of ... generics subsidiary, was incorrect.,The company said it will ... all applicable laws and regulations governing reimbursement rules ...
... Technologies Corporation (NASDAQ:DVAX) announced today that it plans to report third quarter ... , ... BERKELEY, Calif. (Business Wire EON) October 30, 2008 -- ... the Oppenheimer 19th Annual Healthcare Conference in New York City on November ...
... Breast Cancer Survivors Learn about the Importance of ... SAN DIEGO, Oct. 30 A large number ... part of the "Know Your,L-Dex" awareness campaign activities ... Houston and Dallas., (Photo: http://www.newscom.com/cgi-bin/prnh/20081030/NY43020 ...
... Conference Call Scheduled Wednesday, November 5, 2008 at 11:00 a.m.,ET ... AFAM ), a leading regional provider of home health ... third quarter,2008 ended September 30, 2008 on Wednesday, November 5, ... the results will begin at 11:00 a.m. ET on,November 5, ...
... International,Inc. (Nasdaq: DATA ), a technology and services ... industry, today announced that,it will host a conference call ... 2008 at 4:30 p.m. ET on Thursday, November 6, ... to dial 412-858-4600 a,few minutes before 4:30 p.m. ET. ...
Cached Medicine News:Health News:Gentiva(R) Health Services to Present at November Investment Conferences Hosted by Oppenheimer, Credit Suisse and Stephens 2Health News:Gentiva(R) Health Services to Present at November Investment Conferences Hosted by Oppenheimer, Credit Suisse and Stephens 3Health News:Schering-Plough to Appeal Jury Decision in Missouri Reimbursement Case 2Health News: Dynavax to Report Third Quarter 2008 Financial Results : -- To Present at Oppenheimer's Healthcare Conference -- 2Health News:'Know Your L-Dex(TM)' (Lymphedema Index) Awareness Campaign Attracts Large Numbers of Breast Cancer Survivors at Komen Race for the Cure(R) Events 2Health News:'Know Your L-Dex(TM)' (Lymphedema Index) Awareness Campaign Attracts Large Numbers of Breast Cancer Survivors at Komen Race for the Cure(R) Events 3Health News:Almost Family, Inc. to Report Third Quarter 2008 Financial Results 2Health News:DATATRAK International Management to Host Conference Call on November 6, 2008 to Discuss Third Quarter and Nine Month Operating Results for 2008 2Health News:DATATRAK International Management to Host Conference Call on November 6, 2008 to Discuss Third Quarter and Nine Month Operating Results for 2008 3
... SC Strep A is a rapid point-of-care ... Strep A antigen in throat swab specimens. ... use no mixing, measuring or working ... cassette format and clearly visible result window ...
... A Twist Rapid Test Device (Throat Swab) is ... a patented design to provide convenience to the ... swab chamber, eliminating the need for test tubes ... exhibits a 93% accuracy compared to plate culture, ...
... Since 1994 the CoaguChek System has been ... needed most, at the point of care. , ... for thousands of patients self-testing when monitoring on ... the user to obtain a result from a ...
... Ovulation Tests are qualitative immunoassays for detecting elevated ... procedure is fast and results are easy to ... is darker than the control band, then ovulation ... If the test band does not appear ...
Medicine Products: